FHI vs AB
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 28, 2026
FHI
61.6
AI Score
VS
FHI Wins
AB
45.9
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | FHI | AB | Winner |
|---|---|---|---|
| Net Income | 403.30M | 156.96M | FHI |
| ROA | 18.1% | 12.6% | FHI |
| Total Assets | 2.23B | 1.25B | FHI |
Relative Price Performance (Last 90 Days)
FHI 1M: -11.2%
· 3M: +0.5%
AB 1M: -3.0%
· 3M: -0.3%
Current Technical Phase
FHI
NeutralHold
Mixed signals - no dominant trend phase, RSI 40
AB
DistributionTrim / tighten stop
Price near a flattening SMA50 (slope -0.1%) with fading momentum, RSI 42
Fundamentals Snapshot
| Metric | FHI | AB |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.8 | 9.5 |
| Trailing P/E | 10.7 | 10.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | -0.4% |
| Gross Margin | 0.7% | 1.0% |
| Operating Margin | 0.3% | 1.0% |
| EPS | 5.37 | 3.31 |
| Dividend Yield | 0.02% | 0.10% |
Frequently Asked Questions
Based on our detailed analysis, FHI is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.